Sex Specificity in Methadone Analgesia in the Rat: A Population Pharmacokinetic and Pharmacodynamic Approach
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Purpose. To quantify the extent to which a sex-specific dichotomy in the temporal evolution of the analgesic effect, after intravenous (i.v.) methadone injection in the rat, relates to the pharmacokinetics (PK) and pharmacodynamics (PD) that mediate the dose-to-effect pathway.
Methods. Tail-flick analgesia was measured after i.v. methadone injection (0.35 mg/kg) in female (n = 16) and male (n = 16) Sprague-Dawley rats. The PK were evaluated in separate female (n = 56) and male (n = 56) rats after they had received the same dose of methadone i.v. (0.35 mg/kg). A bicompartmental model described the kinetics and a sigmoid Emax model-related drug effect vs. simulated concentrations (pharmacodynamics) at the times of effect measurement. All model parameters as well as interanimal and assay variabilities were estimated with a mixed-effects population method using the program NONMEM.
Results. The area under the effect-time curve (AUCE0-120) was (mean ± interanimal SD) 1859 ± 346 min in the females, which was significantly lower than the 4871 ± 393 min in the males (P < 0.0001). On the contrary, the profiles of concentration vs. time were higher in females and, therefore, corresponded inversely to the effect vs. time-relative magnitudes. The central volume of distribution, V1, was 1.94 ± 0.37 l/kg for female rats and 3.01 ± 0.33 l/kg for male rats. Also, the central clearance was 0.077 ± 0.006 l/min/kg and 0.102 ± 0.005 l/min/kg, respectively, for female and male rats. Both parameters differed significantly between sexes (P < 0.0001). The pharmacodynamic maximum observed effect parameter (Emax) was 37% ± 29% in female rats and 85% ± 16% in male rats, and these values were significantly different (P < 0.0001). The parameter for the concentration eliciting half of Emax (EC50) was 24.1 ± 7.5 μg/l in female rats and 20.3 ± 2.9 μg/l in male rats, and the Hill-related exponent, γ, was 6.3 ± 3.9 in female rats and 5.5 ± 4.1 in male rats. These parameters did not differ significantly (at the P < 0.05 level).
Conclusions. A sex-specific dichotomy in the methadone antinociceptive effect, in the rat, was not proportionally related to plasma concentrations. Each sex corresponded to a distinct subpopulation of the PK parameters and one of the pharmacodynamic parameters (Emax). When the course of a drug involves PK or PD subpopulations, PK/PD modeling can afford the safest prediction of the effect-time evolution for a particular dose.
- A. I. Baamonde, A. Hidelgo, and F. Andres-Trelles. Sex related differences in the effects of morphine and stress on visceral pain. Neuropharmacology 28:967–970 (1989).
- T. J. Cicero, B. Nock, and E. R. Meyer. Gender-related differences in the antinociceptive properties of morphine. J. Pharmacol. Exp. Ther. 279:767–773 (1996).
- T. J. Cicero, B. Nock, and E. R. Meyer. Sex-related differences in morphine´ s antinociceptive activity: Relationship to serum and brain morphine concentration. J. Pharmacol. Exp. Ther. 282:939–944 (1997).
- B. Kest, E. Sarton, and A. Dahan. Gender differences in opioidmediated analgesia. Anesthesiology 93:539–547 (2000).
- R. Z. Harris, L. Z. Benet, and J. B. Schwartz. Gender effects in pharmacokinetics and pharmacodynamics. Drugs 50:222–239 (1995).
- P. A. Thurmann and B. C. Hompesch. Influence of gender on the pharmacokinetics and pharmacodynamics of drugs. Int. J. Clin. Pharmacol. Ther. 36:586–590 (1998).
- B. Beierle. Meibohm, and H. Derendorf. Gender differences in pharmacokinetics and pharmacodynamics. Int. J. Clin. Pharmacol. Ther. 37:529–547 (1999).
- P. L. Bonate. Gender-related differences in xenobiotic metabolism. J. Clin. Pharmacol. 31:684–690 (1991).
- R. Kato and Y. Yamazoe. Sex-specific cytochrome P-450 as a cause of sex-and species-related differences in drug toxicity. Toxicol. Lett. 65:661–667 (1992).
- E. Tanaka. Gender-related differences in pharmacokinetics and their clinical significance. J. Clin. Pharmacol. Ther. 24:339–346 (1999).
- P. A. Routledge, W. W. Stargel, B. B. Kitchell, A. Barchowsky, and D. G. Shand. Sex-related differences in the plasma protein binding of lignocaine and diazepam. Br. J. Clin. Pharmacol. 11:245–250 (1981).
- M. Farrell, J. Ward, R. Mattick, W. Hall, G. V. Stimson, D. des Jarlais, M. Gossop, and J. Strang. Methadone maintenance treatment in opiate dependence: A review. Br. Med. J. 309:997–1001 (1994).
- R. Fainsinger, T. Schoeller, and E. Bruera. Methadone in the management of cancer pain: a review. Pain 52:137–147 (1993).
- C. Ripamonti, E. Zecca, and E. Bruera. An update on the clinical use of methadone for cancer pain. Pain 70:109–115 (1997).
- K. R. Dyer, D. J. Foster, J. M. White, A. A. Somogyi, A. Menelaou, and F. Bochner. Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships. Clin. Pharmacol. Ther. 65:685–694 (1999).
- C. E. Inturrisi, W. A. Colburn, R. F. Kaiko, R. W. Houden, and K. M. Foley. Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain. Clin. Pharmacol. Ther. 41:392–401 (1987).
- K. Wolff, A. Rostami-Hodjegan, S. Shires, A. W. M. Hay, M. Feely, R. Calvert, D. Raistrick, and G. T. Tucker. The pharmacokinetics of methadone in healthy subjects and opiate users. Br. J. Clin. Pharmacol. 44:325–334 (1997).
- C. B. Eap, C. Cuendet, and P. Baumann. Binding of dmethadone, l-methadone and d-l-methadone to protein in plasma of healthy volunteers: Role of the variants of a1-acid glycoprotein. Clin. Pharmacol. Ther. 47:338–346 (1990).
- E. Gomez, R. Martinez-Jorda, E. Suarez, M. J. Garrido, and R. Calvo. Altered methadone analgesia due to changes in plasma protein binding: Role of the route of administration. Gen. Pharmacol. 26:1273–1276 (1995).
- D. Rostami-Hodjegan, W. Wolff, A. W. M. Hay, D. Raistrick, R. Calvert, and G. T. Tucker. Population pharmacokinetics of methadone in opiate users: Characterization of time-dependent changes. Br. J. Clin. Pharmacol. 48:43–52 (1999).
- D. J. Foster, A. A. Somogyi, and F. Bochner. Methadone Ndemethylaction in human liver microsomes: Lack of stereoselectivity and involvement of CYP3A4. Br. J. Clin. Pharmacol. 47:403–412 (1999).
- R. K. Verbeeck. J-A Cardinal, and S. M. Wallace. Effect of age and gender on the plasma binding of acidic and basic drugs. Eur. J. Clin. Pharmacol. 27:91–97 (1984).
- R. E. Bartok and R. M. Craft. Sex differences in opioid antinociception. J. Pharmacol. Exp. Ther. 282:769–778 (1997).
- J. Candido, K. Lutfy, B. Billings, V. Sierra, A. Duttaroy, C. E. Inturrisi, and B. C. Yoburn. Effect of adrenal and sex hormones on opioid analgesia and opioid receptor regulation. Pharmacol. Biochem. Behav. 42:685–692 (1992).
- F. E. D'Amour and D. L. Smith. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:74–79 (1941).
- K. Wolff, M. Sanderson, A. W. M. Hay, and D. Raistrick. Methadone concentrations in plasma and their relationship to drug dosage. Clin. Chem. 37:205–209 (1991).
- M. J. Garrido, M. Valle, R. Calvo, and I. F. Troconiz. Altered plasma and brain disposition and pharmacodynamics of methadone in abstinent rats. J. Pharmacol. Exp. Ther. 288:179–187 (1999).
- E. I. Ette, A. W. Kelman, C. A. Howie, and B. Whiting. Analysis of animal pharmacokinetic data: performance of the one point per animal design. J. Pharmacokinet. Biopharm. 23:551–566 (1995).
- L. B. Sheiner, D. R. Stanski, S. Vozeh, R. D. Miller, and J. Ham. Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine. Clin. Pharmacol. Ther. 25:358–371 (1979).
- A. M. Davis and C. E. Inturrisi. d-Methadone blocks morphine tolerance and N-methyl-d-aspartate induced hyperalgesia. J. Pharmacol Exp. Ther. 289:1048–1053 (1999).
- K. L. Kepler, K. M. Standifer, D. Paul, G. W. Pasternak, B. Kest, and R. J. Bodnar. Gender effects upon central opioid analgesia. Pain 45:87–94 (1991).
- R. M. Craft, J. A. Stratmann, R. E. Bartok, T. I. Walpole, and S. J. King. Sex differences in development of morphine tolerance and dependence in the rat. Psychopharmacology 143:1–7 (1999).
- K. Wolff, A. Rostami-Hodjegan, A. W. M. Hay, D. Raistrick, and G. Tucker. Population based pharmacokinetic approach for methadone monitoring of opiate addicts: Potential clinical utility. Addiction 95:1771–1783 (2000).
- G. S. F. Ling, J. C. Umans, and C. E. Inturrisi. Methadone: Radioimmunoassay and pharmacokinetics in the rat. J. Pharmacol. Exp. Ther. 217:147–151 (1981).
- M.-I. Nilsson, E. Anggard, and J. Holmstrand. and L-M Gunne. Pharmacokinetics of methadone during maintenance treatment: Adaptive changes during the induction phase. Eur. J. Clin. Pharmacol. 22:343–349 (1982).
- K. Wilson, C. N. Reynolds, and D. Burnett. Inter and intraindividual variation in the metabolism of methaqualone in man after a single oral dose. Eur. J. Clin. Pharmacol. 13:291–297 (1978).
- J. D. Lane, J. F. Steege, S. L. Rupp, and C. M. Kuhn. Menstrual cycle effects on caffeine elimination in the human female. Eur. J. Clin. Pharmacol. 43:543–546 (1992).
- M. Rowland and T. N. Tozer. Clinical Pharmacokinetics: Concepts and Applications 3rd Ed. William & Wilkins, Media, PA, 1995 pp. 137–155.
- D. J. Greenblat, H. Friedman, E. S. Burstein, J. M. Scavone, G. T. Blyden, H. R. Ochs, L. G. Miller, J. S. Harmatz, and R. I. Shader. Trazodone kinetics: Effect of age, gender, and obesity. Clin. Pharmacol. Ther. 42:193–200 (1987).
- E. Schwartz, R. S. Matteo, E. Ornstein, W. L. Young, and K. L. Myers. Pharmacokinetics of sufentanil in obese patients. Anesth. Analg. 73:790–793 (1991).
- C. M. Hunt, W. R. Westerkam, and G. M. Stave. Effect of age and gender on the activity of human hepatic CYP3A. Biochem. Pharmacol. 44:275–283 (1992).
- E. K. Krzanowska and R. J. Bodner. Morphine antinociception elicited from the ventrolateral periaductal gray is sensitive to sex and gonadectomy differences in rats. Brain Res. 821:224–230 (1999).
- J. S. Boyer, M. M. Morgan, and R. M. Craft. Microinjection of morphine into rostral ventromedial medulla produces greater antinociception in male compared to female rats. Brain Res. 796:315–318 (1998).
- S. J. Liu, D. L. Roerig, and R. I. H. Wang. Brain and plasma levels of methadone and their relationship to analgesic activity of methadone in rats. Drug Metab. Dispos. 11:335–338 (1983).
- K. Kristensen, C. B. Christensen, and L. L. Christrup. The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine. Life Sci. 56:45–50 (1995).
- K. Kristensen, T. Blemmer, H. R. Angelo, L. L. Christrup, N. E. Drenck, S. M. Rasmussen, and P. Sjogren. Stereoselective pharmacokinetics of methadone in chronic pain patients. Ther. Drug Monitor. 18:221–227 (1996).
- M. A. Carlos, P. du Souich, R. Carlos, E. Suarez, J. C. Lukas, and R. Calvo. Effect of omeprazole on oral and intravenous RS-methadone pharmacokinetics and pharmacodynamics in the rat. J. Pharm. Sci. 91:1627–1638 (2002).
- C. Cordon-Cardo, J. P. O'Brien, D. Casals, L. Rittman-Grauer, J. L. Bierdler, M. R. Melamed, and J. R. Bertino. Multidrug resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. USA 86:695–698 (1989).
- R. Bouer, L. Barthe, C. Philibert, C. Tourmaire, J. Woodley, and G. Houin. The roles of P-glycoprotein and intracellular metabolism in the intestinal absorption of methadone: in vitro studies using the rat-inverted intestinal sack. Fundam. Clin. Pharmacol. 13:494–500 (1999).
- S. J. Thopmson, D. V. M. Kari Koszdin, and C. M. Bernards. Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein. Anesthesiology 92:1392–1399 (2000).
- C. J. R. Parker, J. M. Hunter, and S. L. Snowdon. Effect of age, gender, and anesthetic technique on the pharmacodynamics of atracurium. Br. J. Anaesth. 70:38–41 (1993).
- E. Sarton, E. Olofsen, R. Romberg, J. Hartigh, B. Kest, D. Nieuwenhuijs, A. Burm, L. Teppema, and A. Dahan. Sex differences in morphine analgesia. Anesthesiology 93:1245–1254 (2000).
- R. P. Hammer. Mu-opiate receptor binding in the medial preoptic area is cyclical and sexually dimorphic. Brain Res. 515:187–192 (1990).
- R. B. Simerly, L. Swanson, and R. A. Gorski. Demonstration of a sexual dimorphism in the distribution of serotonin inmunoreactive fevers in the medial preoptic nucleus of the rat. J. Comp. Neurol. 225:151–176 (1984).
- K. L. Kepler, B. Kest, J. M. Kiefel, M. L. Cooper, and R. J. Bodnar. Roles of gender and gonadectomy and estrous phase in the analgesic effects of intracerebroventricular morphine in rats. Pharmacol. Biochem. Behav. 34:119–127 (1989).
- Sex Specificity in Methadone Analgesia in the Rat: A Population Pharmacokinetic and Pharmacodynamic Approach
Volume 19, Issue 6 , pp 858-867
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers-Plenum Publishers
- Additional Links
- sex difference
- nonlinear mixed effects
- Industry Sectors
- Author Affiliations
- 1. Department of Pharmacology, Faculty of Medicine, University of the Basque Country, Leioa, Vizcaya, E-48940, Spain
- 2. Department of Pharmacy, School of Pharmacy, University of Washington, Mail Stop 357630, Seattle, Washington, 98195